Dose-finding methods: Moving away from the 3 + 3 to include richer outcomes

Abstract

The most commonly used method for dose finding, the 3 þ 3, has poor performance. New adaptive designs are more efficient. Nevertheless, they have reached a maximum performance level, and further improvement requires either larger sample sizes or outcomes measures richer than the simplistic severe toxicity measured at cycle 1.